Shelekhin; Tatiana

Patent Applications and Registrations

Patent applications and USPTO patent grants for Shelekhin; Tatiana.The latest application filed is for "inhibiting ubiquitin specific peptidase 9x".

Company Profile

10.11.17

Shelekhin; Tatiana - Ridgefield CT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions for activating pyruvate kinase Grant 11,396,513 - Zheng , et al. July 26, 2	2022-07-26
Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors Grant 11,325,917 - Guerin , et al. May 10, 2	2022-05-10
Inhibiting Ubiquitin Specific Peptidase 9x App 20220041597 - Follows; Bruce ; et al.	2022-02-10
Inhibiting Ubiquitin Specific Peptidase 9x App 20210346356 - LYNES; Maureen ; et al.	2021-11-11
Carboxamides As Ubiquitin-specific Protease Inhibitors App 20210323975 - GUERIN; David J. ; et al.	2021-10-21
Pyrrolopyrrole Compositions As Pyruvate Kinase (pkr) Activators App 20210246143 - ERICSSON; Anna ; et al.	2021-08-12
Inhibiting Deubiquitinase Usp25 And Usp28 App 20210179628 - GUERIN; David J. ; et al.	2021-06-17
Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators Grant 11,014,927 - Ericsson , et al. May 25, 2	2021-05-25
Thienopyrazine Carboxamides As Ubiquitin-specific Protease Inhibitors App 20210047343 - Guerin; David Joseph ; et al.	2021-02-18
Thienopyridine carboxamides as ubiquitin-specific protease inhibitors Grant 10,913,753 - Guerin , et al. February 9, 2	2021-02-09
Compositions For Activating Pyruvate Kinase App 20210017184 - Zheng; Xiaozhang ; et al.	2021-01-21
Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors Grant 10,889,592 - Guerin , et al. January 12, 2	2021-01-12
Compositions for activating pyruvate kinase Grant 10,836,771 - Zheng , et al. November 17, 2	2020-11-17
Pyrrolopyrrole Compositions As Pyruvate Kinase (pkr) Activators App 20200069643 - ERICSSON; Anna ; et al.	2020-03-05
Compositions For Activating Pyruvate Kinase App 20200031839 - Zheng; Xiaozhang ; et al.	2020-01-30
Thienopyridine Carboxamides as Ubiquitin-Specific Protease Inhibitors App 20200017525 - Guerin; David Joseph ; et al.	2020-01-16
Thienopyrazine Carboxamides as Ubiquitin-Specific Protease Inhibitors App 20190359628 - Guerin; David Joseph ; et al.	2019-11-28
Compositions for activating pyruvate kinase Grant 10,472,371 - Zheng , et al. Nov	2019-11-12
Compositions For Activating Pyruvate Kinase App 20190218221 - Zheng; Xiaozhang ; et al.	2019-07-18
Compositions for activating pyruvate kinase Grant 10,208,052 - Zheng , et al. Feb	2019-02-19
Pyrrolo[2,1-f][1,2,4]triazin-4-ylamines IGF-1R kinase inhibitors for the treatment of cancer and other hyperproliferative diseases Grant 8,431,695 - O'Connor , et al. April 30, 2	2013-04-30
Pyrrolo[2,1-F] [1,2,4] Triazin-4-Ylamines IGF-1R Kinase Inhibitors for the Treatment of Cancer and Other Hyperproliferative Diseases App 20110294776 - O'Connor; Stephen ; et al.	2011-12-01
Preparation And Use Of Biphenyl-4-yl-carbonylamino Acid Derivatives For The Treatment Of Obesity App 20110118302 - Smith; Roger ; et al.	2011-05-19
Preparation And Use Of Biphenyl Amino Acid Derivatives For The Treatment Of Obesity App 20100234307 - Smith; Roger A. ; et al.	2010-09-16
Preparation and use of biphenyl-4-yl-carbonylamino acid derivatives for the treatment of obesity Grant 7,759,376 - Smith , et al. July 20, 2	2010-07-20
Preparation and Use of Biphenyl Amino Acid Derivatives for the Treatment of Obesity App 20100016295 - Smith; Roger A. ; et al.	2010-01-21
Preparation and Use of Biphenyl-4-Yl-Carbonylamino Acid Derivatives for the Treatment of Obesity App 20070265298 - Smith; Roger ; et al.	2007-11-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.